Rosario Pivonello Selected Research

Pituitary ACTH Hypersecretion

1/2022	Osilodrostat for the treatment of Cushing's disease: efficacy, stability, and persistence - Authors' reply.
12/2021	Consensus on diagnosis and management of Cushing's disease: a guideline update.
5/2021	Etiology-, Sex-, and Tumor Size-Based Differences in Adrenocorticotropin-Dependent Cushing Syndrome.
3/2021	Corticotroph tumor progression after bilateral adrenalectomy (Nelson's syndrome): systematic review and expert consensus recommendations.
1/2021	Molecular Imaging Targeting Corticotropin-releasing Hormone Receptor for Corticotropinoma: A Changing Paradigm.
1/2021	Glucocorticoid Receptor Antagonism Upregulates Somatostatin Receptor Subtype 2 Expression in ACTH-Producing Neuroendocrine Tumors: New Insight Based on the Selective Glucocorticoid Receptor Modulator Relacorilant.
10/2020	ACTH increment post total bilateral adrenalectomy for Cushing's disease: a consistent biosignature for predicting Nelson's syndrome.
6/2020	Pasireotide treatment significantly reduces tumor volume in patients with Cushing's disease: results from a Phase 3 study.
2/2020	Use of late-night salivary cortisol to monitor response to medical treatment in Cushing's disease.
1/2020	Medical Treatment of Cushing's Disease: An Overview of the Current and Recent Clinical Trials.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rosario Pivonello Research Topics

Disease

53	Acromegaly 09/2019 - 07/2002
51	Neoplasms (Cancer) 01/2022 - 03/2003
36	Cushing Syndrome 01/2022 - 05/2003
36	Pituitary Neoplasms (Pituitary Adenoma) 03/2021 - 04/2003
30	Pituitary ACTH Hypersecretion 01/2022 - 03/2003
20	Prolactinoma (Prolactinomas) 09/2021 - 06/2002
18	Adenoma (Adenomas) 01/2021 - 03/2003
16	Insulin Resistance 01/2021 - 06/2005
15	Hypertension (High Blood Pressure) 12/2021 - 05/2003
9	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 06/2003
9	Parkinson Disease (Parkinson's Disease) 01/2017 - 04/2005
8	Hyperprolactinemia 01/2019 - 06/2002
7	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2021 - 09/2005
7	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2020 - 08/2015
7	Cardiomyopathies (Cardiomyopathy) 07/2019 - 07/2002
7	Diabetes Mellitus 01/2019 - 05/2003
6	Glucose Intolerance 08/2015 - 03/2008
5	Obesity 01/2022 - 05/2003
5	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 12/2003
5	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2021 - 01/2007
5	Adrenocortical Carcinoma 03/2020 - 06/2012
5	Multiple System Atrophy 11/2010 - 04/2005
4	Infections 01/2022 - 01/2018
4	Body Weight (Weight, Body) 01/2022 - 01/2019
4	COVID-19 12/2021 - 01/2020
4	Hyperglycemia 01/2021 - 08/2015
4	Nausea 01/2021 - 08/2015
4	Thyroid Neoplasms (Thyroid Cancer) 01/2017 - 04/2005
4	Cardiovascular Diseases (Cardiovascular Disease) 02/2016 - 11/2007
4	Osteoporosis 01/2016 - 09/2007
4	Abdominal Obesity 01/2016 - 06/2005
3	Inflammation (Inflammations) 01/2022 - 04/2005
3	Dyslipidemias (Dyslipidemia) 12/2021 - 10/2009
3	Cognitive Dysfunction 11/2019 - 02/2013
3	Heart Failure 07/2019 - 01/2004
3	ACTH-Secreting Pituitary Adenoma 01/2019 - 09/2007
3	Diarrhea 04/2016 - 08/2015
3	Hyperplasia 08/2014 - 01/2003
3	Adrenal incidentaloma 11/2013 - 09/2007
3	Carcinoma (Carcinomatosis) 01/2010 - 09/2004
2	Vitamin D Deficiency 01/2022 - 06/2020
2	Weight Gain 01/2022 - 01/2018
2	Infertility (Sterility) 09/2021 - 06/2002
2	Urinary Tract Infections (Urinary Tract Infection) 01/2021 - 01/2020
2	Thrombosis (Thrombus) 01/2021 - 01/2018
2	Vomiting 01/2021 - 08/2015
2	Hypokalemia 01/2021 - 01/2020
2	Muscular Diseases (Myopathy) 10/2020 - 01/2016
2	Female Infertility 03/2020 - 01/2017
2	Substance-Related Disorders (Drug Abuse) 03/2020 - 01/2018
2	Addison Disease (Addison's Disease) 01/2020 - 01/2005

Drug/Important Bio-Agent (IBA)

40	Hydrocortisone (Cortisol)FDA LinkGeneric 02/2021 - 03/2003
37	Insulin-Like Growth Factor I (IGF-1)IBA 09/2019 - 07/2002
33	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2021 - 02/2003
26	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 02/2004
25	Growth Hormone (Somatotropin)IBA 01/2021 - 04/2003
25	Cabergoline FDA LinkGeneric 01/2021 - 06/2002
21	Octreotide (Sandostatin)FDA LinkGeneric 01/2019 - 01/2003
19	Dopamine Agonists (Dopamine Agonist)IBA 09/2021 - 06/2002
18	Adrenocorticotropic Hormone (ACTH)FDA Link 05/2021 - 05/2004
17	Insulin (Novolin)FDA Link 12/2021 - 02/2004
17	Pharmaceutical PreparationsIBA 01/2021 - 04/2004
16	pasireotideIBA 06/2020 - 05/2007
14	GlucocorticoidsIBA 12/2021 - 04/2005
12	lanreotide (Somatuline)FDA Link 06/2016 - 04/2003
10	LipidsIBA 01/2022 - 05/2007
10	ProlactinIBA 09/2021 - 06/2002
10	Dopamine Receptors (Dopamine Receptor)IBA 01/2021 - 04/2004
10	Testosterone (Sustanon)FDA Link 01/2021 - 01/2003
9	Hormones (Hormone)IBA 01/2021 - 06/2002
8	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2021 - 04/2003
6	Insulin-Like PeptidesIBA 09/2019 - 01/2004
5	Vitamin D FDA LinkGeneric 01/2022 - 02/2016
5	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2022 - 08/2015
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 03/2008
5	Bromocriptine (Parlodel)FDA LinkGeneric 01/2019 - 06/2002
4	OsilodrostatIBA 01/2022 - 04/2014
4	relacorilantIBA 01/2022 - 01/2020
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2014
4	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 07/2019 - 04/2005
4	Dopamine (Intropin)FDA LinkGeneric 01/2019 - 04/2008
4	pegvisomant FDA LinkGeneric 03/2017 - 03/2006
4	Arginine (L-Arginine)FDA Link 10/2010 - 04/2005
4	Dopamine Agents (Dopaminergic Agents)IBA 01/2010 - 06/2002
3	Mifepristone (RU 486)FDA Link 01/2021 - 08/2015
3	Protein Isoforms (Isoforms)IBA 11/2019 - 04/2004
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2019 - 12/2003
3	MTOR InhibitorsIBA 01/2019 - 06/2012
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 01/2017
3	AntibodiesIBA 06/2007 - 04/2003
2	Everolimus FDA Link 01/2022 - 12/2019
2	GonadotropinsIBA 01/2021 - 01/2019
2	Mitotane (Lysodren)FDA Link 03/2020 - 06/2016
2	bisphenol AIBA 03/2020 - 10/2016
2	SmokeIBA 03/2020 - 01/2018

Therapy/Procedure

50	Therapeutics 01/2022 - 03/2003
13	Radiotherapy 12/2021 - 04/2007
6	Adrenalectomy 05/2021 - 11/2013
5	Drug Therapy (Chemotherapy) 06/2020 - 01/2006
4	Aftercare (After-Treatment) 01/2021 - 01/2003